AB Science Receives Notice of Allowance for Unites States Patent Covering Masitinib until 2040 in the Treatment of Sickle Cell Disease

AB Science announced that the US Patent Office has issued a Notice of Allowance for a patent relating to methods of treating sickle cell disease with its lead compound masitinib, based on preclinical data.